‘Quality science’: Swisse to launch its first ‘assessed listed’ complementary medicine in Australia next year By Tingmin Koe 01-Nov-2023 - Last updated on 01-Nov-2023 at 11:17 GMT Facebook Twitter Linkedin Email to a friend Swisse is launching its first “assessed listed” complementary medicine – a krill oil product for individuals suffering from mild to moderate osteoarthritis – next year in the Australian market. Read the full story here. NIA top 10 stories Postbiotic approval: Kirin subsidiary’s ingredient approved for use in foods, supplements in India Promotion and formulation: Blackmores eyes China and Indonesia boost, plus NPD with Kirin’s flagship ingredients China HMOs approvals: Two MNCs and one local giant get the green light from regulators ‘Quality science’: Swisse to launch its first ‘assessed listed’ complementary medicine in Australia next year Korea innovation: AI model to speed up identification of new ingredients for health functional foods Dairy the core base, but greater co-existence with plant-based, precision fermented proteins to come – Friesland Campina Is personalised nutrition truly the future? Suntory on the challenging journey to ‘full personalisation’ Asia’s huge women’s health opportunity: Think holistic and cover all life stages to secure market gains - WATCH Malaysia issues advisory on oral aloe vera and links with adverse kidney reactions Infant nutrition innovation: Focus on giving the best benefits, not just innovating with new ingredients – Bayer Consumer Health R&D chief Prev 1 … 3 4 5 6 7 … 11 Next
